EYE NEWS MEDIA

MEETING REPORTER: Dr. Carlton Fenzi discusses his 10-year experience with OMIDRIA? and highlights the significant differences in surgical outcomes between using OMIDRIA? and not using it.

MEETING REPORTER: Since 2007, the Rabb-Venable Excellence in Ophthalmology Program has been supported by NIH/NEI and led by course directors Dr. Mildred M.G. Olivier and Dr. Eydie Miller-Ellis.? Dr. Olivier says the Rabb-Venable Program is dedicated to cultivating culturally competent individuals who reflect the diverse population we serve. Our mission is anchored in the belief that a diversified medical field leads to improved patient health outcomes. By nurturing a community reflective of our patient demographics, we aim to enhance the overall healthcare experience.

MEETING REPORTER: I just returned from my first?Outliers Meeting?in Nashville—and now I understand why this event is gaining so much traction. Now in its fourth year, Outliers is unlike any other meeting I’ve attended. What stood out immediately was the?focus on topics that often get overlooked?at the larger conferences—things like: ? Enhancing the?patient experience ? Integrating?advanced technology?in meaningful ways ? Driving?profitability?without compromising care These are real-world, practice-level conversations that make a difference—and they were front and center all weekend. What made it even better? Hearing directly from passionate, forward-thinking doctors and practice leaders who were generous with their insights and eager to share what’s working for them. Thanks to Robert F. I Melendez, MD, MBA and Josh for creating such a high-value experience for me. #ophthalmology

MEETING REPORTER AT AGS: Nathan Radcliffe, MD at the American Glaucoma Society 2025 meeting in Washington, DC, discusses the critical role of clinical data in glaucoma care. Dr. Radcliffe highlights the importance of clinical data in gaining 510(k) approval for procedures and their real-world effects on patients. He shares insights from a study on the OMNI? Surgical Device using the IRIS? database. The study tracked 200 patients over 36 months and demonstrated impressive intraocular pressure reduction and significant medication reduction, offering a promising standalone treatment for glaucoma patients. #ascrs #aao #escrs #glaucoma #eyedoc #eyesurgery

EYE NEWS MEETING REPORTER: Rebecca Metzinger, MD, explores the advantages of surgeon-delivered medications compared to the traditional three-in-one combination compounded drops for cataract surgery patients. Rayner #ascrs #aao #escrs #cataractsurgery #eyesurgeon

MEETING REPORTER at AGS 2025: Mona Athea Kaleem, MD, is transforming patient care one procedure at a time with the OMNI? Surgical System by Sight Sciences. From #canaloplasty to #goniotomy, it offers safety and durability across different disease stages, in combination with cataract surgery or standalone. #glaucoma #eyedoctor #ascrs #aao #escrs #cataracts

MEETING REPORTER: Steven R. Sarkisian, Jr., MD, talks about his paper at AGS 2025. We are witnessing a revolution in #glaucoma care! The transition towards eyedrop-free treatment is here, with excellent results from iDose? TR: Over 90% of patients are on the same or fewer meds after just one year! #glaucoma #aao #ascrs #aao #eyesurgeon

MEETING REPORTER AGS 2025: Nathan Radcliffe reports from AGS 2025 on a game-changing development in #glaucoma care – the?Iantrek CycloPen?. Dr. Robert Weinreb presented data on a new study involving 51 patients with medically uncontrolled glaucoma. The study reported a 40% reduction in intraocular pressure (IOP) and a 41% reduction in medication use, maintained over 12 months. The biocompatible approach demonstrated excellent safety and efficacy, with impressive IOP reduction in refractory patients. The Iantrek CycloPen? system has shown promising results through two years of data, providing an innovative interventional option for glaucoma patients, particularly those not yet ready for incisional surgeries. This early intervention can play a vital role in slowing disease progression and meeting the needs of approximately 2.5 million glaucoma patients. #aao #ascrs #escrs #glaucomasurgery #eyedoc #optomotry #ophthalmology #eyenewsmedia

MEETING REPORTER Tom Pace from AGS 2025: Dr. Sheybani Arsham from Washington University in St. Louis presented on the?Myra Vision Calibreye TGT Surgical System, a #titratable tube shunt procedure that's making waves in glaucoma treatment. ???Innovative flow control mechanism?for better pressure management ???Significant IOP reduction?– from an average of 23 to 12 ???There was a drastic drop in medication use?– from 3.2 to just 0.12 A promising step forward for glaucoma patients and surgeons alike! The Calibreye TGT Surgical System is for investigational use only and is not for sale in the US or outside the US. #Ophthalmology #Glaucoma #Calibreye #ESCRS #AAO #eyesurgeon #myravision

MEETING REPORTER AT AGS: What does interventional glaucoma mean for your practice? Please tune in to learn about revolutionary techniques and the importance of proactive treatment to keep patients seeing their best. Paul Singh, MD, spoke to Tom Pace from EYE NEWS MEDIA about his MINDSET for treating glaucoma patients. #aao #escrs #ascrs #glaucoma #glaucomapatients #ophthalmologists #optometry